These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7688363)

  • 1. The use of G-CSF during craniospinal irradiation.
    Marks LB; Halperin EC
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):905-6; discussion 907. PubMed ID: 7688363
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of recombinant granulocyte-colony stimulating factor to treat neutropenia occurring during craniospinal irradiation.
    Mac Manus MP; Clarke J; McCormick D; Abram WP
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):845-50. PubMed ID: 7688362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of radiation-induced neutropenia by granulocyte colony-stimulating factor.
    Marks LB; Friedman HS; Kurtzberg J; Oakes WJ; Hockenberger BM
    Med Pediatr Oncol; 1992; 20(3):240-2. PubMed ID: 1374149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony stimulating factor for prevention of craniospinal radiation treatment interruption among central nervous system tumor patients.
    Kalaghchi B; Kazemian A; Hassanloo J; Zendehdel K
    Asian Pac J Cancer Prev; 2010; 11(6):1499-502. PubMed ID: 21338187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib.
    Wang WC; Crist WM; Ihle JN; Arnold BA; Keating JP
    Leukemia; 1991 Apr; 5(4):347-9. PubMed ID: 1709246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of subcutaneous G-CSF or GM-CSF in malignancy.
    Disis ML
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 2):5-9. PubMed ID: 15934493
    [No Abstract]   [Full Text] [Related]  

  • 7. G-CSF and GM-CSF in Neutropenia.
    Mehta HM; Malandra M; Corey SJ
    J Immunol; 2015 Aug; 195(4):1341-9. PubMed ID: 26254266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anesthetic considerations in patients receiving colony-stimulating factors (G-CSF and GM-CSF).
    Tobias JD; Furman WL
    Anesthesiology; 1991 Sep; 75(3):536-8. PubMed ID: 1716081
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of granulocyte colony-stimulating factor for neutropenia after orthotopic liver transplantation: report of two cases.
    Atici AE; Bostanci EB; Ozer I; Ulas M; Akdogan M; Akoglu M
    Transplant Proc; 2011 Apr; 43(3):909-11. PubMed ID: 21486626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF treatment of leucopenia during fractionated radiotherapy.
    Hess CF; Schmidberger H; Bamberg M
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):923-4. PubMed ID: 7518817
    [No Abstract]   [Full Text] [Related]  

  • 11. Granulocyte colony stimulating factor in neutropenic patients with infective endocarditis.
    Borgbjerg BM; Hovgaard D; Laursen JB; Aldershvile J
    Heart; 1998 Jan; 79(1):93-5. PubMed ID: 9505928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Place of G-CSF in allogenic bone marrow grafts].
    Gluckman E
    Pathol Biol (Paris); 1993 Jan; 41(1):51. PubMed ID: 7686288
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukocytoclastic vasculitis in patients with severe congenital neutropenia.
    Kilic SS; Mustafayeva S; Ipek K; Adim SB
    J Trop Pediatr; 2010 Oct; 56(5):359-62. PubMed ID: 20100783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antimicrobial agents and granulocyte colony stimulating factors for febrile neutropenia in cancer patients in a tertiary care hospital in India.
    Roy V; Saxena D; Agarwal M; Bahadur AK; Mishra B
    Indian J Cancer; 2010; 47(4):430-6. PubMed ID: 21131758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutropenia of Felty's syndrome successfully treated with granulocyte colony stimulating factor.
    Fraser DD; Sartiano GP; Butler TW; Treadwell EL
    J Rheumatol; 1993 Aug; 20(8):1447-8. PubMed ID: 7693942
    [No Abstract]   [Full Text] [Related]  

  • 17. [Alloimmune neonatal neutropenia. Treatment with granulocyte colony- stimulating factor].
    Cedena Romero P; Muro Brussi M; García Alonso L; Muñiz Díaz E; Cabanillas Vilaplana L; Sáez Pérez E
    An Esp Pediatr; 1996 Nov; 45(5):536-8. PubMed ID: 9036790
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.
    Barnes G; Pathak A; Schwartzberg L
    Adv Ther; 2014 Jul; 31(7):683-95. PubMed ID: 24989316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuous treatment with colony stimulating factors (G-CSF) for neutropenia associated with type Ib glycogenosis].
    de Diego Fernández P; García Fernández JR; Moreno Madrid F; Sánchez Forte M
    An Esp Pediatr; 2001 Sep; 55(3):282-4. PubMed ID: 11676908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Granulocyte colony-stimulating factor and HIV infection].
    Miguélez M; Laynez P; Linares M
    Med Clin (Barc); 1995 Feb; 104(4):157. PubMed ID: 7534854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.